Olaflur
|
| Systematic (IUPAC) name |
| N,N,N'-tris(2-hydroxyethyl)-N'-octadecylpropane-1,3-diamine dihydrofluoride |
| Clinical data |
| AHFS/Drugs.com |
International Drug Names |
| Pregnancy cat. |
No adequate studies |
| Legal status |
OTC |
| Routes |
Topical (toothpaste, mouthwash, gel) |
| Identifiers |
| CAS number |
6818-37-7 |
| ATC code |
A01AA03 |
| PubChem |
CID 23257 |
| ChemSpider |
21751 |
| UNII |
8NY9L8837D Y |
| Synonyms |
{3-[Octadecyl(2-hydroxyethyl)aminio]propyl}bis(2-hydroxyethyl)amine dihydrofluoride |
| Chemical data |
| Formula |
C27H60F2N2O3 |
| Mol. mass |
498.774 g/mol |
SMILES
- F.F.OCCN(CCCN(CCCCCCCCCCCCCCCCCC)CCO)CCO
|
InChI
-
InChI=1S/C27H58N2O3.2FH/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-19-28(22-25-30)20-18-21-29(23-26-31)24-27-32;;/h30-32H,2-27H2,1H3;2*1H
Key:ZVVSSOQAYNYNPP-UHFFFAOYSA-N
|
Y (what is this?) (verify)
|
Olaflur (INN, or amine fluoride 297) is a fluoride-containing substance that is an ingredient of toothpastes and solutions for the prevention of dental caries.[1] It has been in use since 1966. Especially in combination with dectaflur, it is also used in the form of gels for the treatment of early stages of caries, sensitive teeth, and by dentists for the refluoridation of damaged tooth enamel.[2]
|
Contents
- 1 Overdosage
- 2 Interactions
- 3 Chemistry and mechanism of action
- 4 See also
- 5 References
|
Overdosage[edit]
Overdosage leads to irritation of the oral mucosa. In especially sensitive persons, even standard doses of olaflur can cause irritation.[2]
Like other fluoride salts, olaflur is toxic when given in high doses over an extended period of time. Especially in children, before the development of the permanent teeth, overdosage can lead to dental fluorosis, a discolouring and weakening of the enamel.[3] In acute cases of overdosage, for example when an olaflur containing preparation is swallowed, calcium in any oral form serves as an antidote. Often milk is used because it is usually at hand.[2]
Interactions[edit]
Because calcium fluoride is practically insoluble in water, calcium-containing drugs and food inhibit the action of olaflur.[2]
Chemistry and mechanism of action[edit]
Olaflur is a salt consisting of an alkyl ammonium cation and fluoride as the counterion. With a long lipophilic hydrocarbon chain, the cation has surfactant properties. It forms a film layer on the surface of teeth, which facilitates incorporation of fluoride into the enamel. The top layers of the enamel's primary mineral, hydroxylapatite, are converted into the more robust fluorapatite. The fluoridation reaches only a depth of a few nanometres, which has raised doubts whether the mechanism really relies on the formation of fluorapatite.[4]
Synthesis[edit]
The synthesis of olaflur starts from cattle's tallow.[5] The contained fatty acids, mainly stearic acid (C17H35COOH), are obtained by hydrolysis, and then converted to the corresponding amides, which in turn are reduced catalytically to the primary amines. Addition of acrylonitrile, followed by another reduction, yields N-alkyl-1,3-propanediamines. The two nitrogen atoms react with ethylene oxide (oxirane) to tertiary amines. Finally, hydrofluoric acid is added to give the end product. Because olaflur is produced from a mixture of fatty acids, some molecules have side chains that are longer or shorter than 18 carbon atoms. Other byproducts of the reaction include hydroxyethyl ethers resulting from addition of ethylene oxide to the free hydroxyl groups. The presence of these side products is clinically irrelevant.[5]
See also[edit]
- Fluoride therapy
- Remineralisation of teeth
References[edit]
- ^ Ganss, C.; Klimek, J.; Brune, V.; Schürmann, A. (2004). "Effects of Two Fluoridation Measures on Erosion Progression in Human Enamel and Dentine in situ". Caries Research 38 (6): 561–566. doi:10.1159/000080587. PMID 15528912. edit
- ^ a b c d Haberfeld, H, ed. (2009). Austria-Codex (in German) (2009/2010 ed.). Vienna: Österreichischer Apothekerverlag. ISBN 3-85200-196-X.
- ^ Alvarez, J. A.; Rezende, K. M.; Marocho, S. M.; Alves, F. B.; Celiberti, P.; Ciamponi, A. L. (2009). "Dental fluorosis: Exposure, prevention and management". Medicina oral, patologia oral y cirugia bucal 14 (2): E103–E107. PMID 19179949. edit
- ^ Müller, F.; Zeitz, C.; Mantz, H.; Ehses, K. H.; Soldera, F.; Schmauch, J.; Hannig, M.; Hüfner, S. et al. (2010). "Elemental Depth Profiling of Fluoridated Hydroxyapatite: Saving Your Dentition by the Skin of Your Teeth?". Langmuir 26 (24): 18750–18759. doi:10.1021/la102325e. PMID 21090577. edit
- ^ a b US patent 6464962, Heckendorn, R. & Gosteli, J., "N-Alkyldiethanolamine hydrofluorides and oral hygiene compositions containing them"
|
Stomatological preparations (A01)
|
|
Caries
prophylactic
agents |
- Dectaflur
- Olaflur
- Sodium fluoride
- Sodium monofluorophosphate
- Stannous fluoride
|
|
Anti-infectives
and antiseptics |
- Amphotericin B
- Benzoxonium chloride
- Chlorhexidine
- Chlortetracycline
- Clotrimazole
- Domiphen bromide
- Doxycycline
- Eugenol
- Hexetidine
- Hydrogen peroxide
- Mepartricin
- Metronidazole
- Miconazole
- Minocycline
- Natamycin
- Neomycin
- Oxyquinoline
- Polynoxylin
- Sodium perborate
- Tetracycline
- Tibezonium iodide
|
|
Corticosteroids
(Glucocorticoids) |
- Dexamethasone
- Hydrocortisone
- Triamcinolone
|
|
| Other |
- Amlexanox
- Acetylsalicylic acid
- Becaplermin
- Benzydamine
- Epinephrine/Adrenalone
|
|
|
|
|
noco/cofa (c)/cogi/tumr, sysi
|
|
|
|
|
